Home › Funds › CHARTER RESEARCH & INVESTMENT GROUP, INC. › ABBV

CHARTER RESEARCH & INVESTMENT GROUP, INC. position in ABBV

ABBVIE INC · Health Care

CHARTER RESEARCH & INVESTMENT GROUP, INC. reported holding 4,996 shares of ABBV (ABBVIE INC) in its Q3 2026 13F filing — a position valued at US$1.3M, representing 0.81% of its reported portfolio and ranking #33 among its reported holdings. CHARTER RESEARCH & INVESTMENT GROUP, INC. has disclosed ABBV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)5.00K sh
Reported value held$1.31M
Portfolio Weight0.81%
First reportedQ3 2023
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How CHARTER RESEARCH & INVESTMENT GROUP, INC.'s ABBV position evolved

CHARTER RESEARCH & INVESTMENT GROUP, INC. first disclosed a stake in ABBV in Q3 2023 at 6,034 shares (US$899K). The position peaked in Q3 2026 at 4,996 shares, worth US$1.3M. Across 13 filings, CHARTER RESEARCH & INVESTMENT GROUP, INC. increased the stake 1 time(s), trimmed it 3 time(s) and left it unchanged 8 time(s). The most recent filing (Q3 2026) shows 4,996 shares valued at US$1.3M.

Quarter by quarter

QuarterSharesValueChange
Q3 2023 6.03K $899.43K New
Q4 2023 6.03K $935.09K Hold
Q1 2024 5.68K $1.04M Reduce
Q2 2024 5.68K $974.92K Hold
Q3 2024 5.68K $1.12M Hold
Q4 2024 5.49K $974.86K Reduce
Q1 2025 5.49K $1.15M Hold
Q2 2025 5.49K $1.02M Hold
Q3 2025 5.49K $1.27M Hold
Q4 2025 4.79K $1.09M Reduce
Q1 2026 5.00K $1.09M Add
Q2 2026 5.00K $1.26M Hold
Q3 2026 5.00K $1.31M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABBV and 13F data

ABBV (ABBVIE INC) is a Health Care company. 31 other funds we track also report a position in ABBV — the largest reported positions include Vanguard Group (US$41.31B), BlackRock Inc (US$37.62B), VANGUARD CAPITAL MANAGEMENT LLC (US$30.26B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABBV

All ABBV fund holders →

FAQ

How long has CHARTER RESEARCH & INVESTMENT GROUP, INC. held ABBV?

CHARTER RESEARCH & INVESTMENT GROUP, INC. has disclosed ABBV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is CHARTER RESEARCH & INVESTMENT GROUP, INC.'s current position in ABBV?

As of Q3 2026, CHARTER RESEARCH & INVESTMENT GROUP, INC. holds 5.00K shares of ABBV (ABBVIE INC), valued at $1.31M, representing 0.81% of its reported portfolio and ranking #33.

Has CHARTER RESEARCH & INVESTMENT GROUP, INC. been buying or selling ABBV?

In the latest 13F filing (Q3 2026), CHARTER RESEARCH & INVESTMENT GROUP, INC. held unchanged its position in ABBV. The position peaked in Q3 2026 at 5.00K shares.

Which other funds hold ABBV?

Other major institutional holders of ABBV include Vanguard Group, BlackRock Inc, VANGUARD CAPITAL MANAGEMENT LLC, among 31 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.